Vaxart GAAP EPS of $0.02 in-line, revenue of $39.2M misses by $26.3M
Source: SeekingAlpha
2026-05-07 16:44:35 ET
More on Vaxart
- Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript
- Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript
- Vaxart, Inc. (VXRT) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference - Slideshow
- Vaxart announces $25M share purchase agreement
- Vaxart signals $700M COVID-19 vaccine milestone path as Sanofi partnership advances and 2026 data readouts approach
Read the full article on Seeking Alpha
For further details see:
Vaxart GAAP EPS of $0.02 in-line, revenue of $39.2M misses by $26.3M
Vaxart Inc.
NASDAQ: VXRT
VXRT Trading
-2.28% G/L:
$0.601 Last:
131,865 Volume:
$0.6167 Open:
VXRT Latest News
May 19, 2026 04:01:00 pm
Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
May 07, 2026 04:05:00 pm
Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results
VXRT Stock Data
$141,641,208
233,347,888
0.84%
5
16957900%
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
